Abstract

To illustrate the surgical technique and explore clinical outcomes of the reconstruction for the malignant and metastatic bone tumour of proximal femur with metallic modular intercalary prosthesis. Sixteen patients who underwent modular intercalary prosthetic reconstruction after tumour resection were included from April 2012 and October 2020. Prosthesis and screws parameters, resected bone length and residual bone length, clinical outcomes and survivorship were analyzed. All patients were followed up for an average of 19 months (range 1–74). In our series, 12 patients died of the progression of the primary disease at the final follow-up. The cumulative survivorship since the treatment of proximal femoral metastasis was 78.6% (11 patients) at 6 months and 38.5% (5 patients) at 1 year. The mean MSTS score was 22.25 ± 4.55 among all patients. There were no cases of loosening or breakage of the prostheses, plates or screws, despite the various measurements of prostheses and residual bones. Modular intercalary prosthetic reconstruction was an effective method for malignant tumour of the proximal femur, including the advantages of providing early pain relief, quickly restoring postoperative function, required a short operation time, and preserving the adjacent joints.

Details

Title
Modular intercalary prosthetic reconstruction for malignant and metastatic tumours of the proximal femur
Author
Liu, Lu 1 ; Deng, Xiao-qiang 2 ; Zhao, Yong-jie 3 ; Ma, Rong-xing 4 ; Yang, Li 5 ; Song, Kun-xiu 3 ; Zhang, Jing-yu 6 ; Hu, Yong-cheng 6 

 Tianjin Medical University, Graduate School, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228); Xing’anmeng People’s Hospital, Ulanhot, China (GRID:grid.265021.2) 
 Xing’anmeng People’s Hospital, Ulanhot, China (GRID:grid.265021.2) 
 Binzhou Medical University Hospital, Binzhou, China (GRID:grid.440653.0) (ISNI:0000 0000 9588 091X) 
 Tianjin Medical University, Graduate School, Tianjin, China (GRID:grid.265021.2) (ISNI:0000 0000 9792 1228) 
 Beijing Jishuitan Hospital Guizhou Hospital, Guiyang, China (GRID:grid.414360.4) (ISNI:0000 0004 0605 7104) 
 Tianjin Hospital, Department of Bone Tumor and Soft Tissue Oncology, Tianjin, China (GRID:grid.417028.8) (ISNI:0000 0004 1799 2608) 
Pages
5867
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2955124620
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.